Inventor · disambiguated record
David D. Wirth
Also filed as: WIRTH DAVID · WIRTH DAVID D · WIRTH DAVID DALE
30 granted patents·11 pending applications·347 citations·filing 1985–2024
97Inventor score
Top patents by PatentIndex Score
41 records- 0199US9725455B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Aug 8, 2017·25 cites·13 claims
- 0299US9713617B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted Jul 25, 2017·28 cites·41 claims
- 0398US10125140B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Nov 13, 2018·18 cites·4 claims
- 0498US9828383B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Nov 28, 2017·20 cites·31 claims
- 0598US9296753B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Mar 29, 2016·84 cites·18 claims
- 0697US10961251B1Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·14 claims
- 0797US10294231B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·11 cites·28 claims
- 0897US10106548B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Oct 23, 2018·13 cites·30 claims
- 0997US9840492B2Antifungal compounds and processes for makingVIAMET PHARMACEUTICALS INC·Filed 2016·Granted Dec 12, 2017·17 cites·6 claims
- 1097US9540382B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Jan 10, 2017·43 cites·31 claims
- 1196US10294232B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·9 cites·29 claims
- 1296US10065968B2Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Sep 4, 2018·10 cites·22 claims
- 1395US10752634B2Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·3 cites·28 claims
- 1494US10266540B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Apr 23, 2019·5 cites·23 claims
- 1588US2024409545A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 1687US10414751B2Antifungal compounds and processes for makingMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Sep 17, 2019·2 cites·12 claims
- 1779US2022112196A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 1878US10676459B2Antifungal compounds and processes for makingMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Jun 9, 2020·1 cites·12 claims
- 1977US2021032258A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 2076US10370353B2Antifungal compounds and processes for makingMYCOVIA PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·11 claims
- 2176US2019248799A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2276US2019248798A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2375US2020231595A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 2475US2020148691A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 2572US2018155352A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2672US2018170940A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2771US5196585AProcess for treating dinitroanilines with sulfite to reduce impurities and to reduce the ability to produce nitrosaminesDOWELANCO·Filed 1990·Granted Mar 23, 1993·11 cites·5 claims
- 2871US2017305919A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 2970US2014336203A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 3066US4703118ASynthesis of 3-iodomethyl cephalosporinsLILLY CO ELI·Filed 1985·Granted Oct 27, 1987·11 cites·10 claims
- 3165US10836740B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Nov 17, 2020·0 cites·19 claims
- 3261US5608043AProcess for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose compoundsLILLY CO ELI·Filed 1996·Granted Mar 4, 1997·11 cites·8 claims
- 3360US5559222APreparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranoseLILLY CO ELI·Filed 1995·Granted Sep 24, 1996·11 cites·5 claims
- 3457US10513505B2Antifungal compound processNQP 1598 LTD·Filed 2016·Granted Dec 24, 2019·0 cites·27 claims
- 3557US10464921B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·0 cites·17 claims
- 3656US10308632B2Antifungal compounds and processes for makingVPS 3 INC·Filed 2016·Granted Jun 4, 2019·0 cites·3 claims
- 3750US5602262AProcess for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranoseLILLY CO ELI·Filed 1995·Granted Feb 11, 1997·6 cites·19 claims
- 3848US8664433B2Synthesis of 4-[3-(2,6-dimethylbenzyloxy)phenyl]-4-oxobutanoic acidCHINN JASON P·Filed 2009·Granted Mar 4, 2014·0 cites·20 claims
- 3945US8703991B2Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acidsWIRTH DAVID D·Filed 2009·Granted Apr 22, 2014·0 cites·14 claims
- 4034US5635613AProcess for preparing crystal forms and solvates of dirithromycinLILLY CO ELI·Filed 1995·Granted Jun 3, 1997·3 cites·16 claims
- 4132US5021564AProcess for preparing ceftazidime pentahydrateLILLY CO ELI·Filed 1990·Granted Jun 4, 1991·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when David D. Wirth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →